Skip to content

Comparing the effects of Shallomin and Podophyllin solution 25% in treatment of genital HPV warts in women

Comparing the effects of Shallomin( a pure fraction of shallot extract) and Podophyllin solution 25% in treatment of genital HPV warts in women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011531949N1
Enrollment
60
Registered
2017-03-05
Start date
2017-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital warts. Anogenital (venereal) warts

Interventions

Intervention 1: In the first group, shalomin will be used for treatment, using an applicator to apply it on the lesion. Preparation of medicines: To develop pure fractions of shallot, tuber roots of t
Treatment - Drugs
In the second group podophyllin solution, 25% is applied with an applicator on the lesion. Before using the drug the surrounding of the lesion is coated with zinc oxide cream. Patients were advised to
In the first group, shalomin will be used for treatment, using an applicator to apply it on the lesion. Preparation of medicines: To develop pure fractions of shallot, tuber roots of the plant in the

Sponsors

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: genital HPV warts under 2cm exclusion criteria:age under 15; breast feeding; pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tratment of genital warts. Timepoint: 6 week later. Method of measurement: Visit with dermatologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shadab Shahali

Ahvaz Jundishapur University of Medical Sciences

shahali-sh@ajums.ac.ir+98 61 3373 8189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026